Fig. 2From: Glibenclamide and metfoRmin versus stAndard care in gEstational diabeteS (GRACES): a feasibility open label randomised trialFasting and post-prandial home blood glucose readings in women with GDM treated with metformin and randomised to glibenclamide (G1-13 Panels a and c) or insulin (I 1-10 Panels b and d)Back to article page